Skip to main content

Table 1 Baseline characteristics of ATA-negative and ATA-positive patients

From: The impact of thyroid autoantibodies on the cycle outcome and embryo quality in women undergoing intracytoplasmic sperm injection

Variable ATA negative (n = 250) ATA positive (n = 65) p
Female age (years) 31.4 ± 4.5 31.1 ± 4.9 0.47
BMI (kg/m2) 26.0 ± 19.6 25.8 ± 5.7 0.27
Duration of infertility (years) 4.9 ± 3.6 5.0 ± 4.3 0.70
Basal FSH (mIU/mL) 7.0 ± 2.4 6.9 ± 3.2 0.43
Basal E2 (pg/mL) 41.1 ± 29.5 49.3 ± 22.9 0.67
AMH (ng/mL) 4.3 ± 3.0 3.8 ± 2.3 0.34
TSH (μIU/L) 1.9 ± 0.8 1.8 ± 0.9 0.44
Free T3 (ng/dL) 3.2 ± 0.4 3.2 ± 0.4 0.86
Free T4 (ng/dL) 1.3 ± 0.2 1.5 ± 0.4 0.001
  1. ATA anti-thyroid antibody, BMI body mass index, FSH follicle-stimulating hormone, E2 estradiol, AMH anti-mullerian hormone, TSH thyroid-stimulationg hormone
  2. Values are mean ± SD